rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17 Mar ' 16
Income
Operating income 831.81 728.29 571.00 543.71 563.73
Expenses
Material consumed 307.86 234.28 183.64 175.95 201.65
Manufacturing expenses 7.72 8.27 8.30 7.68 7.43
Personnel expenses 216.70 197.40 153.53 162.04 169.35
Selling expenses - - - - -
Adminstrative expenses 178.83 217.04 179.24 161.10 168.88
Expenses capitalised - - - - -
Cost of sales 711.11 656.99 524.71 506.77 547.31
Operating profit 120.70 71.30 46.29 36.94 16.42
Other recurring income 12.99 16.29 12.25 14.39 6.77
Adjusted PBDIT 133.69 87.59 58.54 51.33 23.19
Financial expenses 1.14 - - - -
Depreciation 18.58 14.92 14.74 15.83 17.43
Other write offs - - - - -
Adjusted PBT 113.97 72.67 43.80 35.50 5.76
Tax charges 41.76 18.22 17.89 15.45 0.50
Adjusted PAT 72.21 54.45 25.91 20.05 5.26
Non recurring items -4.92 -0.60 -2.28 -1.05 -
Other non cash adjustments - - - - -
Reported net profit 67.29 53.85 23.63 19.00 5.26
Earnigs before appropriation 235.38 168.22 114.37 90.74 25.53
Equity dividend 1.99 - - - -
Preference dividend - - - - -
Dividend tax 0.51 - - - -
Retained earnings 232.88 168.22 114.37 90.74 25.53

Mutual Fund Selector

Find the fund that is right for you
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close